| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 05/14/2008 | CN100387277C Preparation method of notoginseng-containing tablet for treating traumatic injury |
| 05/14/2008 | CN100387257C Chinese medicine for treating fractures and processing technology thereof |
| 05/14/2008 | CN100387242C American ginseng and royal jelly soft capsule |
| 05/14/2008 | CN100387231C Process for preparing colatemo solid preparation and its solid preparation |
| 05/14/2008 | CN100387223C Quassia injection and its preparation method |
| 05/13/2008 | US7371895 antiinflammatory agents; autoimmune and cardiovascular disorders; atherosclerosis, rheumatoid arthritis, hyperlipemia; better water solubility increases the bioavailability and pharmacokinetics |
| 05/13/2008 | US7371820 Nutraceuticals for the treatment, protection and restoration of connective tissues |
| 05/13/2008 | US7371819 Differs from nucleotide sequence of wild-type IFN alpha -17 gene, in that it comprises one or several SNPs (Single Nucleotide Polymorphism[s]); anticarcinogenic and antiproliferative agents; side effect reduction |
| 05/13/2008 | US7371777 Such as 2-(3-{[(4-ethoxybenzoyl)amino]methyl}-4-ethoxybenzyl)-tetrahydro-2-furancarboxylic acid; antihyperglycemia and antihyperlipemia action |
| 05/13/2008 | US7371772 Bicyclic compound, production and use thereof |
| 05/13/2008 | US7371765 Quinoline derivatives having VEGF inhibiting activity |
| 05/13/2008 | US7371756 Use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts |
| 05/13/2008 | US7371754 Tyrosine kinase inhibitors |
| 05/13/2008 | US7371747 Cyanoalkylamino derivatives as protease inhibitors |
| 05/13/2008 | US7371744 Photosensitizers for photodynamic therapy; killing tissue, cells; anticancer agents |
| 05/13/2008 | US7371735 Inhibitor oligonucleotides and their use for specific repression of a gene |
| 05/13/2008 | US7371572 A conjugated drug contains virus-like particle is joined to the antigen by a biotin molecule; bioassay; inhibiting HIV infection, viral infection |
| 05/13/2008 | US7371383 Genetic enginieered mixtures of complementary determining regions(CDR) antigens used for analyzing neutralizing epitopes and for prophylaxis of allergies and respiratory system disorders |
| 05/13/2008 | US7371382 Grafting antibodies to nucleic acids; anticancer agents, osteoporosis, vision defects, antiinflammatory agents, skin disorders |
| 05/13/2008 | US7371373 For diagnosis, prevention, or treatment of diseases responsive to therapy with interferon- beta; free of human serum albumin; stability |
| 05/13/2008 | CA2437814C Human monoclonal antibodies to fc alpha receptor (cd89) |
| 05/13/2008 | CA2410234C 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3']bipyridinyl in pure crystalline form and process for synthesis |
| 05/13/2008 | CA2310222C New composition of matter |
| 05/13/2008 | CA2283326C An aqueous metal bicarbonate solution and method of use |
| 05/13/2008 | CA2255856C Therapeutic uses for an aminosterol compound |
| 05/13/2008 | CA2206119C Irrigation solution and method for inhibition of pain, inflammation and spasm |
| 05/08/2008 | WO2008054892A2 Chitin micro-particles as an adjuvant |
| 05/08/2008 | WO2008054639A2 Use of a catechin or polyphenol to treat ocular diseases and infection |
| 05/08/2008 | WO2008054594A2 Method for controlling angiogenesis in animals |
| 05/08/2008 | WO2008054292A1 Pyrazolyl derivatives with analgesic activity and therefore useful in the treatment or prophylaxis of pain. |
| 05/08/2008 | WO2008054291A1 Pyrazolyl derivatives with analgesic activity and therefore useful in the treatment or prophylaxis of pain. |
| 05/08/2008 | WO2008054188A1 Synergistic pharmaceutical composition comprising lysine clonixinate and carisoprodol |
| 05/08/2008 | WO2008053913A1 Sulfonylurea derivative capable of selectively inhibiting mmp-13 |
| 05/08/2008 | WO2008053892A1 Pharmaceutical for promoting functional regeneration of damaged tissue |
| 05/08/2008 | WO2008053863A1 Novel compound having 1,4-benzothiazin-3-one skeleton or 3,4-dihydroquinolin-2-one skeleton |
| 05/08/2008 | WO2008053861A1 Novel compound having 1,4-benzoxazin-3-one skeleton |
| 05/08/2008 | WO2008053352A2 Phenylpropionamide compounds and the use thereof |
| 05/08/2008 | WO2008053331A1 Alpha-substituted omega-3 lipids that are activators or modulators of the peroxisome proliferators-activated receptor (ppar). |
| 05/08/2008 | WO2008053158A1 Inhibitors of p38 mitogen-activated protein kinase |
| 05/08/2008 | WO2008053131A1 Hydroxamates as inhibitors of histone deacetylase |
| 05/08/2008 | WO2008053049A1 Modulators of cell adhesion molecules and use thereof |
| 05/08/2008 | WO2008052808A1 Cyclic phenyl-substituted indazols, a process for their production and their use as anti-inflammatory agents |
| 05/08/2008 | WO2008052733A1 Imidazopyridazines as pi3k lipid kinase inhibitors |
| 05/08/2008 | WO2008052288A1 Dithiole compounds as cox inhibitors |
| 05/08/2008 | WO2008036379A3 Serine hydrolase inhibitors |
| 05/08/2008 | WO2008027350A3 Acetaminophen pharmaceutical compositions |
| 05/08/2008 | WO2008004127A3 Method for administering tolperisone |
| 05/08/2008 | WO2007113285A3 Mono- and bifunctional molecules with ability to bind to g protein-coupled receptors |
| 05/08/2008 | WO2007060038A3 Preparation, comprising iron(iii) complex compounds and redox-active substances |
| 05/08/2008 | US20080108808 Dipeptidyl peptidase inhibitors |
| 05/08/2008 | US20080108807 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile |
| 05/08/2008 | US20080108796 Human IL-1 epsilon DNA and polypeptides |
| 05/08/2008 | US20080108708 Method for Producing Albumin Conjugates Containing Gyrase Inhibitors |
| 05/08/2008 | US20080108652 Acute/chronic inflammatory disease of peripheral organs and central nervous system (CNS) |
| 05/08/2008 | US20080108647 Treatment of HIV and diseases of immune dysregulation |
| 05/08/2008 | US20080108641 Compounds for treating inflammatory disorders, demyelinating disdorders and cancers |
| 05/08/2008 | US20080108636 compounds that form covalent bonds with Bruton's tyrosine kinase (Btk). Also described are irreversible inhibitors of Btk. Methods for the preparation of the compounds are disclosed. Also disclosed are pharmaceutical compositions that include the compounds. Methods of using the Btk inhibitors are told |
| 05/08/2008 | US20080108634 Novel phenylalanine derivatives |
| 05/08/2008 | US20080108628 Treatment of diseases or disorders mediated by T lymphocytes and/or PKC; may be coadminstered with an immunosuppressant, immunomodulatory, anti-inflammatory, antiproliferative or anti-diabetic drug |
| 05/08/2008 | US20080108621 Aminopterin Dosage Forms and Methods for Inflammatory Disorders |
| 05/08/2008 | US20080108584 dsRNA with a sense strand containing a first sequence, an antisense strand containing a second sequence, comprises a nucleotide sequence which is substantially complementary to mRNA encoding IKK-B, upon contact with a cell expressing IKK-B, Inhibits IKK-B gene expression; antiinflammatory agent |
| 05/08/2008 | US20080108548 Food Composition For Rapidly Attenuating Inflammatory Responses |
| 05/08/2008 | US20080108546 Novel Human Card-Only Protein That Inhibits Pro-Il-1 Beta Maturation |
| 05/08/2008 | US20080107759 Bamboo of Sasa genus or Phyllostachys genus; extracted with water, alcohol, non-polar hexane, ethyl acetate, chloroform and dichloromethane |
| 05/08/2008 | US20080107746 Anti-inflamatory inhalation pharmaceutical composition |
| 05/08/2008 | US20080107720 Topical delivery of codrugs |
| 05/08/2008 | US20080107677 Culture filtrate concentrate from Basidiomycetes; Parkinson's disease; diabetes |
| 05/08/2008 | US20080107627 Use of sarp-1 for the treatment and/or prevention of scleroderma |
| 05/08/2008 | DE102006049452A1 Substituierte Tetrahydropyrolopiperazin-Verbindungen und deren Verwendung in Arzneimitteln Tetrahydropyrolopiperazin substituted compounds and their use in medicaments |
| 05/08/2008 | CA2685724A1 New use 541 |
| 05/08/2008 | CA2668321A1 Pyrazolyl derivatives with analgesic activity and therefore useful in the treatment or prophylaxis of pain |
| 05/08/2008 | CA2668070A1 Hydroxamates as inhibitors of histone deacetylase |
| 05/08/2008 | CA2667960A1 Imidazopyridazines as pi3k lipid kinase inhibitors |
| 05/08/2008 | CA2667864A1 Formulations of phospholipase enzyme inhibitors |
| 05/08/2008 | CA2667211A1 Alpha-substituted omega-3 lipids that are activators or modulators of the peroxisome proliferators-activated receptor (ppar) |
| 05/08/2008 | CA2666750A1 Phenylpropionamide compounds and the use thereof |
| 05/08/2008 | CA2656112A1 Bioresponsive polymers |
| 05/08/2008 | CA2636788A1 Pharmaceuticals that promote functional regeneration of damaged tissues |
| 05/07/2008 | EP1918716A2 Screening for agents modulating TGF-Beta cell signalling |
| 05/07/2008 | EP1918377A1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 05/07/2008 | EP1918299A1 Modulators of cell adhesion molecules and use thereof |
| 05/07/2008 | EP1918279A2 1-(4-piperidinyl)-1,3-dihydro-2h-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and opioid receptor like receptor (ORL1) ligands for the treatment of pain |
| 05/07/2008 | EP1918278A1 Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases |
| 05/07/2008 | EP1917963A1 Cyclic phenyl-substituted indazols, a process for their production and their use as anti-inflammatory agents |
| 05/07/2008 | EP1917273A2 Apoe mimetic agents |
| 05/07/2008 | EP1917260A2 Process to obtain dibenzylbutyrolactonic, tetrahydrofuranic lignans and their synthetic and semi-synthetic derivatives, their analgesic and anti-inflammatory activities, topical and/or systemic formulations containing said lignans and their respective therapeutic method |
| 05/07/2008 | EP1917012A1 Cell migration modulating compounds |
| 05/07/2008 | EP1917010A2 Compositions and methods for treating vascular, autoimmune and inflammatory diseases |
| 05/07/2008 | EP1735295B1 Antiinflammatory lactones |
| 05/07/2008 | EP1545602B1 Pharmaceutical compositions comprising an hiv envelope protein and cd4 |
| 05/07/2008 | EP1509216B1 Active ingredient salts and esters of 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol and 3-(3-dimethylamino-1-ethyl-1-hydroxy-2-methyl-propyl)-phenol |
| 05/07/2008 | EP1436272B1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 05/07/2008 | EP1434792B1 Peptidyl ketones as inhibitors of dpiv |
| 05/07/2008 | EP1395269B1 Lipoteichoic acid from lactic acid bacteria for use as medicament and in the treatment of bacterial diseases |
| 05/07/2008 | EP1380593B1 Soluble rage protein |
| 05/07/2008 | EP1250325B1 Phenanthridine-n-oxides |
| 05/07/2008 | EP0991758B1 Smad6 and uses thereof |
| 05/07/2008 | CN101175755A N- [3- (1-amin0-5, 6, 7, 8-tetrahydro-2 , 4, 4b-triazafluoren-9-yl)-phenyl] benzamides as tyrosine/threonine kinase inhibitors, in particular b-raf kinase |
| 05/07/2008 | CN101175754A Novel tetrahydro-1h-pyrido [4,3-b] indole derivatives as cb1' receptor ligands |
| 05/07/2008 | CN101175753A Compounds and compositions as protein kinase inhibitors |